Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for cognitive dysfunction after traumatic brain injury
IRCT20151123025202N50Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amantadine in traumatic brain injury (TBI), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Change in cognitive function and Change in quality of life. Started Jan 2026; status: completed.
02
Drugs
amantadine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20151123025202N50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151123025202N50.